Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Eflornithine

Eflornithine is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase. Eflornithine is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women.

Product Specifications

CAS Number

[70052-12-9]

Product Name Alternative

DFMO; MDL71782; RMI71782; α-difluoromethylornithine

UNSPSC

12352211

Hazard Statement

H302, H312, H332

Target

Parasite

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection; Cancer

Assay Protocol

https://www.medchemexpress.com/eflornithine.html

Purity

99.87

Solubility

H2O : 83.33 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

NC(CCCN)(C(F)F)C(O)=O

Molecular Formula

C6H12F2N2O2

Molecular Weight

182.17

Precautions

H302, H312, H332

References & Citations

[1]Burri C, et al. Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res. 2003 Jun;90 Supp 1:S49-52.|[2]Balfour JA, et al. Topical eflornithine. Am J Clin Dermatol. 2001;2 (3) :197-201; discussion 202.|[3]Kumar A, et al. A method to improve the efficacy of topical eflornithine hydrochloride cream. Drug Deliv. 2016 Jun;23 (5) :1495-501.|[4]Lipke DW, et al. Eflornithine alters changes in vascular responsiveness associated with coarctation hypertension. Clin Exp Hypertens. 1997 Apr;19 (3) :297-312.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

Trypanosoma

Citation 01

Adv Sci (Weinh) . 2025 Nov 21:e12508.|bioRxiv. 2024 Jan 15.|Cancer Nanotechnol. 2023 May 9.|Cell Rep. 2025 Feb 28;44 (3) :115370.|Clin Cancer Res. 2025 Nov 20.|Commun Biol. 2019 May 8:2:171.|Food Biosci. 2023 Oct, 55, 102970.|J Cardiovasc Transl Res. 2025 Jun;18 (3) :459-470.|JACC Basic Transl Sci. 2022 Aug 3;7 (8) :820-840.|Nat Commun. 2024 Mar 19;15 (1) :2461.|Oncotargets Ther. 2020 Nov 17;13:11697-11709.|Preprints. 2025 May 22.|RSC Adv. 2019 Apr 9;9 (20) :11026-11037.|The University of Texas at San Antonio. 2025.|Cell Rep. 2025 Jan 28;44 (1) :115123.|Front Oncol. 2021 Mar 11:11:636373.|Immunity. 2025 Aug 12;58 (8) :2019-2034.e11.|Phytomedicine. 2025 Jun:141:156660.|Sci Adv. 2023 May 19;9 (20) :eade0718.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Rabbit Monoclonal CCL2/JE/MCP-1 Antibody (017) [Alexa Fluor 700]
NBP2-90551AF700 0.1 mL

Rabbit Monoclonal CCL2/JE/MCP-1 Antibody (017) [Alexa Fluor 700]

Ask
View Details
Lentiviral mouse Nyap2 shRNA (UAS) - Lentiviral mouse Nyap2 shRNA (UAS, iRFP) (100)
GTR15224319 1 Vial

Lentiviral mouse Nyap2 shRNA (UAS) - Lentiviral mouse Nyap2 shRNA (UAS, iRFP) (100)

Ask
View Details
TSCOT (SLC46A2) (NM_033051) Human Tagged ORF Clone
RG208241 10 µg

TSCOT (SLC46A2) (NM_033051) Human Tagged ORF Clone

Ask
View Details
Monoclonal Antibody to Cytokeratin 19 (CK19)
MBS2152871-01 0.1 mL

Monoclonal Antibody to Cytokeratin 19 (CK19)

Ask
View Details
Monoclonal Antibody to Cytokeratin 19 (CK19)
MBS2152871-02 0.2 mL

Monoclonal Antibody to Cytokeratin 19 (CK19)

Ask
View Details
Monoclonal Antibody to Cytokeratin 19 (CK19)
MBS2152871-03 0.5 mL

Monoclonal Antibody to Cytokeratin 19 (CK19)

Ask
View Details